141
Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:September 20, 2013Unknown status
Stage III Multiple Myeloma: 436 Clinical Trials, Page 15 of 44
Hide Studies Not Open or Pending
142
Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
Condition(s):Multiple Myeloma; Plasma Cell NeoplasmLast Updated:July 4, 2016Completed
143
Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide and Planning to Undergo Autologous Stem Cell Transplant
Condition(s):Multiple Myeloma; Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:May 14, 2015Completed
144
Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:November 16, 2018Terminated
145
Bortezomib and Vorinostat in Treating Patients With Multiple Myeloma Who Have Undergone Autologous Stem Cell Transplant
Condition(s):DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell MyelomaLast Updated:May 9, 2017Completed
146
PAD. ICORG 05-01, V11
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:December 31, 2014Completed
147
Study of DNA Samples From Patients With Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:May 19, 2017Completed
148
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Condition(s):Multiple Myeloma; Plasma Cell NeoplasmLast Updated:November 8, 2019Completed
149
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:October 17, 2019Completed
150
FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition(s):DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma; Refractory Plasma Cell MyelomaLast Updated:March 17, 2015Completed